We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

190 hedge funds and large institutions have $1.51B invested in Spectrum Pharmaceuticals Inc in 2018 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 76 increasing their positions, 49 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

55% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 49

55% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 22

18% more call options, than puts

Call options by funds: $21.9M | Put options by funds: $18.5M

6% more funds holding

Funds holding: 180190 (+10)

20% less capital invested

Capital invested by funds: $1.87B → $1.51B (-$365M)

Holders
190
Holders Change
+10
Holders Change %
+5.56%
% of All Funds
4.34%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
34
Increased
76
Reduced
49
Closed
22
Calls
$21.9M
Puts
$18.5M
Net Calls
+$3.38M
Net Calls Change
-$6.31M
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
$2.36M -$229K -10,602 -7%
New York State Teachers Retirement System (NYSTRS)
52
New York State Teachers Retirement System (NYSTRS)
New York
$2.28M +$28.5K +1,315 +1%
First Trust Advisors
53
First Trust Advisors
Illinois
$2.28M +$2.41M +111,513 +463%
GC
54
Guggenheim Capital
Illinois
$2.24M -$38.5K -1,781 -1%
PPA
55
Parametric Portfolio Associates
Washington
$2.13M -$253K -11,672 -8%
Marshall Wace
56
Marshall Wace
United Kingdom
$2M +$2.58M +119,176 New
Canada Life
57
Canada Life
Manitoba, Canada
$1.97M
Point72 Asset Management
58
Point72 Asset Management
Connecticut
$1.97M -$1.83M -84,383 -42%
TCM
59
Tekla Capital Management
Massachusetts
$1.93M +$2.48M +114,670 New
New York State Common Retirement Fund
60
New York State Common Retirement Fund
New York
$1.85M
State of Wisconsin Investment Board
61
State of Wisconsin Investment Board
Wisconsin
$1.7M
KCM
62
Kennedy Capital Management
Missouri
$1.63M -$4.87M -224,998 -70%
QI
63
QS Investors
New York
$1.55M +$1.99M +92,050 New
Hudson Bay Capital Management
64
Hudson Bay Capital Management
Connecticut
$1.51M +$1.95M +90,000 New
BHMP
65
Bardin Hill Management Partners
New York
$1.47M -$1.57M -72,662 -45%
SCA
66
Secor Capital Advisors
New York
$1.46M +$1.88M +86,896 New
Bank of America
67
Bank of America
North Carolina
$1.43M -$1.93M -89,033 -51%
AIG
68
American International Group
New York
$1.33M +$71.2K +3,288 +4%
CAM
69
ClariVest Asset Management
California
$1.3M -$1.55M -71,635 -48%
HI
70
HBK Investments
Texas
$1.27M +$1.16M +53,584 +244%
Comerica Bank
71
Comerica Bank
Texas
$1.27M -$70.1K -3,237 -3%
CS
72
Credit Suisse
Switzerland
$1.24M -$632K -29,186 -28%
MAP
73
Moody Aldrich Partners
Massachusetts
$1.19M +$96K +4,437 +7%
SCM
74
Sio Capital Management
New York
$1.19M -$1.58M -72,838 -51%
Public Sector Pension Investment Board (PSP Investments)
75
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.15M +$169K +7,824 +13%

SPPI Hedge Fund Activity: Q3 2018 in Review

190 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2018, worth a combined $1.51B — down 20% from $1.87B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new SPPI positions and 22 closed out — a net gain of 12 holders — while 76 added to existing stakes and 49 trimmed.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $50.5M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $71.7M sold.

  • 190 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2018, up from 180 in Q2 2018.
  • Funds reported $1.51B of Spectrum Pharmaceuticals Inc stock for Q3 2018, down 20% quarter-over-quarter.
  • 34 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2018 and 22 closed out, a net change of +12 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q3 2018 was ArrowMark Colorado Holdings, an estimated $50.5M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q3 2018 was Avoro Capital Advisors, an estimated $71.7M sold.

Based on aggregated 13F filings for Q3 2018.